XENETIC BIOSCIENCES, INC. SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount
XENETIC BIOSCIENCES, INC. (XBIO) had SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount of $22.76 million as of 2017-12-31, per its 10-K filed 2018-03-30.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesBalance · last filed 2018-03-30
- 2017-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $22.76M.
- 2016-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $21.50M.
- 2015-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $15.32M.
- 2014-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $13.77M; SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount as first filed -$13.77M.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount | SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount as first filed |
|---|---|---|
| 2017-12-31 | $22.76M 10-K · filed 2018-03-30 | |
| 2016-12-31 | $21.50M 10-K · filed 2018-03-30 | |
| 2015-12-31 | $15.32M 10-K · filed 2018-03-30 | |
| 2014-12-31 | $13.77M 10-K · filed 2017-03-31 | -$13.77M 10-K · filed 2015-04-15 |
| 2013-12-31 | $9.52M 10-K · filed 2016-03-30 | -$9.52M 10-K · filed 2015-04-15 |
| 2012-12-31 | -$9.15M 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |